591 related articles for article (PubMed ID: 24240882)
1. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
Johnson MS; Sarkisian SR
J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
[TBL] [Abstract][Full Text] [Related]
2. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
Salimi A; Kovalyuk N; Harasymowycz PJ
J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials.
Ji Q; Qi B; Liu L; Guo X; Zhong J
J Glaucoma; 2015; 24(5):e88-94. PubMed ID: 25264995
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
Castejón MA; Teus MA; Bolivar G; Paz-Moreno-Arrones J; Castaño B
J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004
[TBL] [Abstract][Full Text] [Related]
5. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
[TBL] [Abstract][Full Text] [Related]
6. Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C.
Dada T; Kusumesh R; Bali SJ; Sharma S; Sobti A; Arora V; Panda A
J Glaucoma; 2013; 22(8):659-62. PubMed ID: 23059478
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
8. Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
Menda SA; Lowry EA; Porco TC; Stamper RL; Rubin MR; Han Y
Int Ophthalmol; 2015 Jun; 35(3):357-63. PubMed ID: 24920197
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
Cillino S; Di Pace F; Cillino G; Casuccio A
Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953
[TBL] [Abstract][Full Text] [Related]
10. Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.
Nash DL; Crouch ER; Crouch ER
J Glaucoma; 2017 Feb; 26(2):e58-e63. PubMed ID: 28146442
[TBL] [Abstract][Full Text] [Related]
11. The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
Quist MS; Brown N; Bicket AK; Herndon LW
J Glaucoma; 2018 Feb; 27(2):148-156. PubMed ID: 29189540
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
Senthil S; Rao HL; Babu JG; Mandal AK; Garudadri CS
Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259
[TBL] [Abstract][Full Text] [Related]
13. Phacotrabeculectomy using collagen matrix implant (Ologen
Wlaź A; Wilkos-Kuc A; Rozegnał-Madej A; Żarnowski T
Acta Ophthalmol; 2019 Sep; 97(6):e817-e826. PubMed ID: 30924600
[TBL] [Abstract][Full Text] [Related]
14. Trabeculectomy With Mitomycin C or Ahmed Valve Implantation in Eyes With Uveitic Glaucoma.
Bettis DI; Morshedi RG; Chaya C; Goldsmith J; Crandall A; Zabriskie N
J Glaucoma; 2015; 24(8):591-9. PubMed ID: 25393037
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Biological Evaluations of Biodegradable Collagen Matrices for Glaucoma Drainage Device Implantation.
Song M; Lee S; Choe D; Kim S; Roh YH; Rho S
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5329-5335. PubMed ID: 29049735
[TBL] [Abstract][Full Text] [Related]
16. Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
Marey HM; Mandour SS; Ellakwa AF
J Ocul Pharmacol Ther; 2013 Apr; 29(3):330-4. PubMed ID: 23113645
[TBL] [Abstract][Full Text] [Related]
17. Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
Shalaby HS; Hashem NH
Klin Monbl Augenheilkd; 2022 Sep; 239(9):1147-1154. PubMed ID: 34198351
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Narayanaswamy A; Perera SA; Htoon HM; Hoh ST; Seah SK; Wong TT; Aung T
Clin Exp Ophthalmol; 2013 Aug; 41(6):552-60. PubMed ID: 23279607
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma.
Angmo D; Wadhwani M; Upadhyay AD; Temkar S; Dada T
J Glaucoma; 2017 Jan; 26(1):8-14. PubMed ID: 27599174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
